This inventor holds 1 USPTO granted patent. Top assignee: Isconova Ab. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Carlos Concha Baschunan
Introduction
Carlos Concha Baschunan is a notable inventor based in Santiago, Chile. He has made significant contributions to the field of vaccine development, particularly through his innovative work involving fibronectin binding proteins. His research aims to enhance vaccine efficacy against various microorganisms.
Latest Patents
Carlos holds a patent for a "Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide." This invention relates to a composition that includes at least one fibronectin binding protein, a truncated fibronectin binding protein, and/or a fibronectin binding peptide. These components are designed to work in conjunction with an Iscom matrix complex, liposome, or lipid and saponin, which may be in complex, solution, or suspension form. The patent also describes a kit that contains compartments for the fibronectin binding protein and instructions for use, as well as a method for vaccinating individuals.
Career Highlights
Carlos Concha Baschunan is associated with Isconova AB, a company known for its advancements in vaccine technology. His work has led to the development of innovative solutions that could potentially improve public health outcomes.
Collaborations
Throughout his career, Carlos has collaborated with esteemed colleagues such as Birgitta Fromgren and Jill Ekstrom. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Carlos Concha Baschunan's contributions to vaccine development through his innovative patent highlight the importance of research in combating infectious diseases. His work exemplifies the potential of scientific innovation to improve health outcomes globally.